Log In
BCIQ
Print this Print this
 

VM-902A

  Manage Alerts
Collapse Summary General Information
Company VM Pharma LLC
DescriptionPeripherally acting allosteric neurotrophic tyrosine kinase receptor 1 (TrkA; NTRK1) inhibitor
Molecular Target Neurotrophic tyrosine kinase receptor 1 (TrkA) (NTRK1)
Mechanism of ActionTrkA antagonist
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase I
Standard IndicationPain
Indication DetailsTreat chronic pain
Regulatory Designation
PartnerPurdue Pharma L.P.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

$213.0M

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

09/08/2015

$213.0M

Undisclosed

Undisclosed

Get a free BioCentury trial today